Choose Your News
Loading...
Tags:
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the... [Read More]
Thumbnail
BOTHELL/CAMBRIDGE (EUA) e OSAKA (Japão) -- --dez 7, 2018--Seattle Genetics, Inc. (Nasdaq:SGEN) e Takeda Pharmaceutical Company Limited (TSE:4502) anunciaram que os dados do ensaio clínico... [Read More]
Thumbnail
AS BEFITS A deal in the medical industry, this one has been rather hard to swallow. But on December 5th, eight months after Takeda, Japan's... [Read More]
Thumbnail
Takeda Pharmaceutical Co. shareholders' approval of the $62 billion (about ¥7 trillion) acquisition of Shire PLC is good news for its bosses' ambitions to... [Read More]
Thumbnail
BOTHELL, Washington, CAMBRIDGE, Massachusetts und OSAKA, Japan -- --Dez 6, 2018--Seattle Genetics, Inc. (Nasdaq:SGEN) und Takeda Pharmaceutical Company Limited (TSE:4502) gaben bekannt, dass die Daten... [Read More]
Thumbnail
Scott Takeda hopes he can remove the stigma around the condition -- and using marijuana to help treat it. [Read More]
Christophe Weber, the chief executive officer of Takeda Pharmaceutical Co., has faced a string of challenges in his $62 billion pursuit of U.K.-listed drugmaker Shire... [Read More]
Thumbnail
Read more about Despite 'massive debt' concerns, Takeda investors back $59 bn Shire deal on Business Standard. Takeda shares have fallen around 25 per cent... [Read More]
Thumbnail
BOTHELL, État de Washington, CAMBRIDGE, État du Massachusetts, et OSAKA, Japon -- --déc. 5, 2018... [Read More]
BOTHELL, Washington, CAMBRIDGE, Massachusetts y OSAKA, Japón -- --dic. 5, 2018--Seattle Genetics, Inc. (Nasdaq:SGEN) y Takeda Pharmaceutical Company Limited (TSE:4502) anunciaron que los datos del... [Read More]
BOTHELL, Washington, CAMBRIDGE, Massachusetts y OSAKA, Japón -- --dic. 5, 2018--Seattle Genetics, Inc. (Nasdaq:SGEN) y Takeda Pharmaceutical Company Limited (TSE:4502) anunciaron que los datos del... [Read More]
* Shire rises after Takeda approves takeover deal (Adds closing prices, details) [Read More]
Takeda Pharmaceutical has won shareholder approval for its $59 billion takeover of London-listed Shire , creating a global powerhouse that has a stronger drugs... [Read More]
Takeda Pharmaceutical Co. received shareholder approval for its $62 billion acquisition of Shire Plc. [Read More]
Takeda Pharmaceutical shareholders approved on Wednesday its $59 billion takeover of London-listed Shire, creating a global powerhouse with a stronger drugs pipeline but one that... [Read More]
The £46bn merger between Shire and Takeda has won approval from shareholders, paving the way for the deal to be completed as early as January... [Read More]
Takeda Pharmaceutical shareholders approved on Wednesday its $59 billion takeover of London-listed Shire , creating a global powerhouse with a stronger drugs pipeline but... [Read More]
Shareholders of Takeda have backed the £46 billion takeover of Shire despite opposition from the founding family.In a general meeting in Osaka at least 88 per cent... [Read More]
Shareholders express concern, however, for company's debt load... [Read More]
Loading...
Preview